Clovis Oncology Reports Interim Results From Rubraca Phase 2 Study In Advanced Pancreatic Cancer, Nonclinical Data In Multiple Solid Tumor Types For Rucaparib, Lucitanib Presented At AACR Meeting
Benzinga Newsdesk